Press
release
Montpellier, France, April 30, 2021 - 6:00pm CEST
Publication of the annual financial report
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and Myrian® designer (the "Company"), today announces the publication of its annual financial report for the financial year ended on December 31, 2020.
Growth of financial aggregates
The annual financial report reflects the Group's positive financial performance, with the main financial aggregates showing an increase despite the difficult economic context in 2020.
These good results illustrate the work of the teams and the outcomes of the Company's structuring. 2020 also marks a new phase in the Group's development, posting operational profitability for the first time of its history.
Intrasense is entering a new phase of growth with enthusiastic technical, commercial and managerial teams and an innovation strategy in line with its growth ambitions in its target markets. The Company's 2020 objectives have been fully achieved and 2021 looks promising. To finance its growth strategy while maintaining a strong balance sheet structure, Intrasense considers raising capital in line with market conditions and the progress of its development plan.
The annual financial report can be consulted and downloaded, as of today, in the Investors section of the Company's website (in French only): https://www.intrasense.fr/fr/investisseurs/#doc-financiere.
Main financial aggregates:
- Salesupby3.7%despitetheimpactofthehealthcrisis
- EBITDAupby€554kandatbreakevenforthefirsttime
- Cashpositionstrengthenedtoapproximately€2.5M
- SuccessfulcompletionoftheGroup'sstructuringphaseinitiatedin2018
Page 1/2
About Intrasense
Founded in 2004, Intrasense develops and markets a unique medical device named Myrian®, a software platform facilitating and ensuring diagnosis, decision-making and therapeutic follow-up. Thanks to Myrian®, more than 1000 hospitals and clinics spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner…). Enriched with expert clinical modules dedicated to specific pathologies and organs, Myrian® provides a universal medical image processing solution which can be fully integrated into any healthcare information system. Intrasense has more than 40 employees among which 15 are dedicated to Research & Development. Intrasense has been labelled 'innovative company' by the BPI and has invested more than 10 million euros in Research & Development since its creation. More information on: www.intrasense.fr
Contacts
Intrasense | NewCap |
Jérémy Peyron | Investor Relations and Financial |
Marketing & Communication manager | Communication |
1231 avenue du Mondial 98, 34000 | Louis Tilquin |
Montpellier, FRANCE | Paris, FRANCE |
Tel: +334 67 130 130 | Tel: +331 44 71 20 40 |
investor@intrasense.fr | intrasense@newcap.eu |
Page 2/2
Attachments
- Original document
- Permalink
Disclaimer
Intrasense SA published this content on 30 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 April 2021 15:24:05 UTC.